Point72 Asset Management L.P. Increases Stock Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Point72 Asset Management L.P. increased its stake in shares of Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 33.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,179,863 shares of the health services provider's stock after acquiring an additional 2,813,568 shares during the quarter. Point72 Asset Management L.P. owned approximately 6.49% of Teladoc Health worth $101,625,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. increased its position in shares of Teladoc Health by 5.9% during the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider's stock worth $167,830,000 after acquiring an additional 1,029,829 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of Teladoc Health by 15.5% in the fourth quarter. Renaissance Technologies LLC now owns 5,674,542 shares of the health services provider's stock worth $51,582,000 after purchasing an additional 763,265 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Teladoc Health by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 3,947,831 shares of the health services provider's stock valued at $35,894,000 after purchasing an additional 22,664 shares in the last quarter. Maple Rock Capital Partners Inc. boosted its position in shares of Teladoc Health by 189.5% during the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider's stock valued at $32,369,000 after buying an additional 2,331,000 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its holdings in Teladoc Health by 0.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,531,492 shares of the health services provider's stock worth $32,104,000 after buying an additional 8,890 shares in the last quarter. 76.82% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Adam C. Vandervoort sold 11,011 shares of Teladoc Health stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total value of $92,712.62. Following the transaction, the insider now directly owns 64,308 shares of the company's stock, valued at $541,473.36. The trade was a 14.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.58% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

TDOC has been the topic of a number of analyst reports. Needham & Company LLC reaffirmed a "hold" rating on shares of Teladoc Health in a report on Thursday, May 1st. Wells Fargo & Company cut their target price on Teladoc Health from $10.00 to $8.00 and set an "equal weight" rating on the stock in a research note on Thursday, May 8th. Citigroup lowered their price objective on shares of Teladoc Health from $11.00 to $8.75 and set a "neutral" rating on the stock in a research report on Friday, April 25th. The Goldman Sachs Group dropped their target price on shares of Teladoc Health from $13.00 to $10.00 and set a "buy" rating on the stock in a research note on Thursday, May 1st. Finally, Bank of America lowered their price target on shares of Teladoc Health from $9.50 to $8.00 and set a "neutral" rating on the stock in a report on Friday, April 11th. Twelve research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $9.71.

Teladoc Health Price Performance

Shares of Teladoc Health stock traded up $0.20 during trading on Tuesday, hitting $7.51. The stock had a trading volume of 1,196,137 shares, compared to its average volume of 6,836,941. The firm has a market cap of $1.32 billion, a price-to-earnings ratio of -1.30 and a beta of 1.82. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21. The business's 50-day moving average is $7.55 and its 200 day moving average is $9.35. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) EPS for the quarter, missing analysts' consensus estimates of ($0.21) by ($0.07). The company had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. As a group, sell-side analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.